Results 31 to 40 of about 3,274,326 (383)

Tumor Immunology and Tumor Evolution: Intertwined Histories

Immunity, 2020
Jérôme Galon, Daniela Bruni
exaly   +2 more sources

NLRC5, a promising new entry in tumor immunology. [PDF]

J Immunother Cancer, 2016
The recent use of T cell-based cancer immunotherapies, such as adoptive T-cell transfer and checkpoint blockade, yields increasing clinical benefit to patients with different cancer types. However, decrease of MHC class I expression is a common mechanism
Chelbi ST, Guarda G.
europepmc   +2 more sources

Editorial: New Insights into the Complexity of Tumor Immunology in B-cell Malignancies: Tumor Immunology and Immunotherapy [PDF]

Frontiers in Oncology, 2022
Martina Seiffert, Etienne Moussay, Jérôme Paggetti   +2 more
doaj   +2 more sources

Tumor Immunology

, 2016
At least three times during the history of immunology, investigators proposed that a function of the immune response is to eliminate nascent tumors. Paul Ehrlich initially hypothesized that tumors arise spontaneously in the body and that the immune response protected the individual against the majority of these malignancies.
Douglas M. Templeton, Michael Schwenk, Reinhild Klein, John H. Duffus   +3 more
openalex   +4 more sources

Editorial: New Insights Into the Complexity of Tumor Immunology in B-Cell Malignancies: Prognostic and Predictive Biomarkers and Therapy. [PDF]

Front Oncol, 2021
Moussay E, Seiffert M, Paggetti J.
europepmc   +3 more sources

Cancer Stem Cell Immunology: Key to Understanding Tumorigenesis and Tumor Immune Escape? [PDF]

Frontiers in Immunology, 2014
Jörg Wischhusen
exaly   +2 more sources

Immunology of Tumor Infiltrating Lymphocytes

Annals of Surgery, 1985
Frequently peripheral blood lymphocytes (PBL) do not reflect the tumor host relationship and cell mediated immunity in the PBL does not often correlate with prognosis. The tumor infiltrating lymphocytes (TIL) interact most closely with the tumor cells and are likely to more accurately reflect tumor host interactions.
E. Carmack Holmes
openalex   +4 more sources

The role of MUC16 in tumor biology and tumor immunology in ovarian cancer. [PDF]

BMC Cancer
Yang N, Zhou X, Gong Y, Deng Z.
europepmc   +2 more sources

From cold to hot: mechanisms of hyperthermia in modulating tumor immunology for enhanced immunotherapy. [PDF]

Front Immunol
Abreu MM, Chocron AF, Smadja DM.
europepmc   +2 more sources

"Tumor immunology meets oncology" (TIMO), 18 April-20 April 2024, in Brandenburg an der Havel, Germany. [PDF]

Cancer Immunol Immunother
Seliger B.
europepmc   +3 more sources